Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37315268

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Aug 10
First author
Kaiser MF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2023 Oct 5;13(10):OF1. doi: 10.1158/2159-8290.CD-NB2023-0057.
    note
    Source null
    related pmid
    37560918
    relationship
    Comment in

Authors and identifiers

  1. name
    Kaiser MF
    type
    Author
  2. name
    Hall A
    type
    Author
  3. name
    Walker K
    type
    Author
  4. name
    Sherborne A
    type
    Author
  5. name
    De Tute RM
    type
    Author
  6. name
    Newnham N
    type
    Author
  7. name
    Roberts S
    type
    Author
  8. name
    Ingleson E
    type
    Author
  9. name
    Bowles K
    type
    Author
  10. name
    Garg M
    type
    Author
  11. name
    Lokare A
    type
    Author
  12. name
    Messiou C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kaiser MF
    type
    Author
  2. name
    Hall A
    type
    Author
  3. name
    Walker K
    type
    Author
  4. name
    Sherborne A
    type
    Author
  5. name
    De Tute RM
    type
    Author
  6. name
    Newnham N
    type
    Author
  7. name
    Roberts S
    type
    Author
  8. name
    Ingleson E
    type
    Author
  9. name
    Bowles K
    type
    Author
  10. name
    Garg M
    type
    Author
  11. name
    Lokare A
    type
    Author
  12. name
    Messiou C
    type
    Author
bibliography ids
  1. nci-bib-842aae10fd69649e252264c7
book metadata
content sha256
70e243e7585f1027679f5e9fa3092e075beba91fee8f33275dfe33f7012c57d6
document type
citation
dois
  1. 10.1200/JCO.22.02567
electronic publication date
display
2023 Jun 14
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37315268
immutable id
pubmed:37315268@70e243e7585f1027679f5e9fa3092e075beba91fee8f33275dfe33f7012c57d6
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
23
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3945-3955
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2023 Oct 5;13(10):OF1. doi: 10.1158/2159-8290.CD-NB2023-0057.
    note
    Source null
    related pmid
    37560918
    relationship
    Comment in
outcomes validated
false
pmid
37315268
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
3e0b00229f39384cc683adc635425f4c12e337e358fc0624fdcfad16cb06013e
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Aug 10
precision
day
year
2023
publication types
  1. Multicenter Study
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37315268/
title
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.

Preserved source evidence · Not medical advice